Literature DB >> 25280339

Analysis of microRNA-203 function in CREB/MITF/RAB27a pathway: comparison between canine and human melanoma cells.

S Noguchi1, M Kumazaki2, T Mori3, K Baba4, M Okuda4, T Mizuno1, Y Akao2.   

Abstract

MicroRNA (miR)-203 is downregulated and acts as an anti-oncomir in melanoma cells. Here, using human and canine melanoma cells, we elucidated the effects of miR-203 on cyclic adenosine monophosphate response element binding protein (CREB)/microphthalmia-associated transcription factor (MITF)/RAB27a pathway, which is known to be important for the development and progression of human melanoma. In this study, we showed that miR-203 directly targeted CREB1 and regulated its downstream targets, MITF and RAB27a. miR-203 significantly suppressed the growth of human and canine melanoma cells and inhibited melanosome transport through the suppression of the signalling pathway. In conclusion, miR-203 was shown to be a common tumour-suppressive miRNA in human and canine melanoma and thus to play a crucial role in the biological mechanisms of melanoma development.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  CREB/MITF/RAB27a pathway; cell signalling; comparative oncology; melanoma; microRNA-203

Mesh:

Substances:

Year:  2014        PMID: 25280339     DOI: 10.1111/vco.12118

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  11 in total

Review 1.  Pivotal MicroRNAs in Melanoma: A Mini-Review.

Authors:  Zhenjun Deng; Jingang Hao; Dongyun Lei; Yongjing He; Lechun Lu; Li He
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

Review 2.  Understanding the CREB1-miRNA feedback loop in human malignancies.

Authors:  Ya-Wen Wang; Xu Chen; Rong Ma; Peng Gao
Journal:  Tumour Biol       Date:  2016-04-09

3.  Diagnostic and prognostic values of tissue hsa-miR-30c and hsa-miR-203 in prostate carcinoma.

Authors:  Ziling Huang; Long Zhang; Xianghua Yi; Xiaoting Yu
Journal:  Tumour Biol       Date:  2015-10-24

Review 4.  MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention.

Authors:  Anita Thyagarajan; Ahmed Shaban; Ravi Prakash Sahu
Journal:  J Pharmacol Exp Ther       Date:  2017-10-20       Impact factor: 4.030

5.  An Improved microRNA Annotation of the Canine Genome.

Authors:  Luca Penso-Dolfin; Ross Swofford; Jeremy Johnson; Jessica Alföldi; Kerstin Lindblad-Toh; David Swarbreck; Simon Moxon; Federica Di Palma
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

Review 6.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

7.  miR-203 Inhibits Frizzled-2 Expression via CD82/KAI1 Expression in Human Lung Carcinoma Cells.

Authors:  Mariko Mine; Kojiro Yamaguchi; Tsuyoshi Sugiura; Satomi Chigita; Naoya Yoshihama; Rumi Yoshihama; Naomi Hiyake; Yosuke Kobayashi; Yoshihide Mori
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

Review 8.  Control of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic target.

Authors:  André Steven; Barbara Seliger
Journal:  Oncotarget       Date:  2016-06-07

9.  Identification of MicroRNA Targeting Mlph and Affecting Melanosome Transport.

Authors:  Jeong Ah Lee; Seok Joon Hwang; Sung Chan Hong; Cheol Hwan Myung; Ji Eun Lee; Jong Il Park; Jae Sung Hwang
Journal:  Biomolecules       Date:  2019-07-08

Review 10.  Implication of the p53-Related miR-34c, -125b, and -203 in the Osteoblastic Differentiation and the Malignant Transformation of Bone Sarcomas.

Authors:  Camille Jacques; Robel Tesfaye; Melanie Lavaud; Steven Georges; Marc Baud'huin; François Lamoureux; Benjamin Ory
Journal:  Cells       Date:  2020-03-27       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.